Literature DB >> 25172555

The blood-brain barrier in neuroimmunology: Tales of separation and assimilation.

W A Banks1.   

Abstract

Neuroimmunology is concerned with the relations between the central nervous and immune systems and with the mechanisms that drive those relations. The blood-brain barrier (BBB) employs mechanisms that both separate and connect these two systems. In fact, the relative immune privilege of the central nervous system (CNS) is largely attributable to the BBB's ability to prevent the unregulated exchange of immune cells and their secretions between the CNS and blood. Having separated the two systems, the BBB then participates in mechanisms that allow them to influence, communicate, and interact with one another. Likewise, the BBB itself is influenced by immune events that are occurring in the periphery and in the CNS so that these three components (the BBB, the immune system, and the CNS) form neuroimmune axes that adapt to physiological and pathological conditions. To date, four major themes have emerged by which the BBB participates in these neuroimmune axes. The first of these four, the formation of the barrier, acts to separate the immune and central nervous systems. The other three themes provide mechanisms for re-establishing communication: response of the BBB to immunomodulatory molecules (e.g., prostaglandins, cytokines, chemokines, nitric oxide) secreted by immune and CNS cells; the controlled, regulated exchange of chemokines, cytokines, and immune cells between the CNS and the blood (i.e., transport across the BBB); the secretion of immunomodulatory molecules by the BBB, often in a polarized fashion. Taken together, these mechanisms reveal the BBB to be a dynamic, interactive, and adaptable interface between the immune system and the CNS, separating them on the one hand and fostering their interactions on the other hand, adjusting to physiological changes, while being a target for disease processes. This review examines specific examples by which the BBB plays an interactive, defining role in neuroimmunology. Published by Elsevier Inc.

Entities:  

Keywords:  Blood-brain barrier; Brain endothelial cell; Central nervous system; Cytokine; Immune cells; Neuroimmunology; Pericyte

Mesh:

Substances:

Year:  2014        PMID: 25172555      PMCID: PMC4275374          DOI: 10.1016/j.bbi.2014.08.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  90 in total

1.  Studies on the blood brain barrier. I. Effects produced by a single injection of gramnegative endotoxin on the permeability of the cerebral vessels.

Authors:  P L ECKMAN; W M KING; J G BRUNSON
Journal:  Am J Pathol       Date:  1958 Jul-Aug       Impact factor: 4.307

Review 2.  Neurovascular mechanisms of Alzheimer's neurodegeneration.

Authors:  Berislav V Zlokovic
Journal:  Trends Neurosci       Date:  2005-04       Impact factor: 13.837

3.  Transcellular transport of CCL2 across brain microvascular endothelial cells.

Authors:  Shujun Ge; Li Song; David R Serwanski; William A Kuziel; Joel S Pachter
Journal:  J Neurochem       Date:  2008-03       Impact factor: 5.372

4.  Release of prostaglandin E-2 in bovine brain endothelial cells after exposure to three unique forms of the antifungal drug amphotericin-B: role of COX-2 in amphotericin-B induced fever.

Authors:  Timothy R McGuire; William J Trickler; Lynette Hock; Amy Vrana; Eric B Hoie; Donald W Miller
Journal:  Life Sci       Date:  2003-04-25       Impact factor: 5.037

5.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

6.  Blood interleukin-6 and tumor necrosis factor-alpha elevation after intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors: peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism.

Authors:  G Chen; R S McCuskey; S Reichlin
Journal:  Neuroimmunomodulation       Date:  2000       Impact factor: 2.492

7.  Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.

Authors:  J D Huber; V S Hau; L Borg; C R Campos; R D Egleton; T P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-13       Impact factor: 4.733

8.  Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum.

Authors:  W A Banks; S A Farr; M E La Scola; J E Morley
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

9.  Energy intake is associated with endotoxemia in apparently healthy men.

Authors:  Jacques Amar; Rémy Burcelin; Jean Bernard Ruidavets; Patrice D Cani; Josette Fauvel; Marie Christine Alessi; Bernard Chamontin; Jean Ferriéres
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

10.  Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrier.

Authors:  Shinya Dohgu; Jan S Ryerse; Sandra M Robinson; William A Banks
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

View more
  77 in total

Review 1.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

2.  Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study.

Authors:  Alai Tan; Brent Sullenbarger; Ruchika Prakash; Jodi C McDaniel
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-04-03       Impact factor: 4.006

3.  Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis.

Authors:  Michelle A Erickson; Joseph Jude; Hengjiang Zhao; Elizabeth M Rhea; Therese S Salameh; William Jester; Shelley Pu; Jenna Harrowitz; Ngan Nguyen; William A Banks; Reynold A Panettieri; Kelly L Jordan-Sciutto
Journal:  FASEB J       Date:  2017-05-22       Impact factor: 5.191

Review 4.  Neuroimmune Communication in Health and Disease.

Authors:  Colin Reardon; Kaitlin Murray; Alan E Lomax
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  Endothelial Adora2a Activation Promotes Blood-Brain Barrier Breakdown and Cognitive Impairment in Mice with Diet-Induced Insulin Resistance.

Authors:  Masaki Yamamoto; De-Huang Guo; Caterina M Hernandez; Alexis M Stranahan
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

6.  Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.

Authors:  Sergio M de Almeida; Indianara Rotta; Yanxin Jiang; Xiao Li; Sonia M Raboni; Clea E Ribeiro; Davey Smith; Michael Potter; Florin Vaida; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2016-07-11       Impact factor: 2.643

Review 7.  Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.

Authors:  Andrew H Miller; Ebrahim Haroon; Jennifer C Felger
Journal:  Neuropsychopharmacology       Date:  2016-08-24       Impact factor: 7.853

8.  Cognitive impairment effects of early life stress in adolescents can be predicted with early biomarkers: Impacts of sex, experience, and cytokines.

Authors:  Rodrigo Grassi-Oliveira; Jennifer A Honeycutt; Freedom H Holland; Prabarna Ganguly; Heather C Brenhouse
Journal:  Psychoneuroendocrinology       Date:  2016-04-30       Impact factor: 4.905

Review 9.  Interactions between the microbiota, immune and nervous systems in health and disease.

Authors:  Thomas C Fung; Christine A Olson; Elaine Y Hsiao
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

Review 10.  Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis.

Authors:  Lucineia Gainski Danielski; Amanda Della Giustina; Marwa Badawy; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.